Problem statement: Answer the multiple choice question.
Query: Which drug exhibits a -49.021% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a: COc1cc(NC(=O)c2c(F)c(F)c(F)c(F)c2F)c(OC)cc1Cl
b: CC(C)CC1NC(=O)N(Cc2cc(=O)n3ccsc3n2)C1=O
Answer: b. CC(C)CC1NC(=O)N(Cc2cc(=O)n3ccsc3n2)C1=O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC(C)CC1NC(=O)N(Cc2cc(=O)n3ccsc3n2)C1=O
CC(C)CC1NC(=O)N(Cc2cc(=O)n3ccsc3n2)C1=O
5-(2-methylpropyl)-3-[(5-oxo-[1,3]thiazolo[3,2-a]pyrimidin-7-yl)methyl]imidazolidine-2,4-dione